I don't think that BIT has another 12 months in it either.
No decent research avenue and I can't see a lot of people interested in just putting funds into BIT at this stage either. Bit is somewhat directionless at the moment.
Dengue is just nor "sexy" enough for the markets and they don't seem to know where to go with HIV. One would thin this is the money earner.
Antiviral research is a possibility but, even here, they don't sound optimistic or motivated.
BIT Price at posting:
2.1¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)